I agree that this site is using cookies. You can find further informations here.
X
Bergmeijer, Thomas O.
69  results:
Search for persons X
?
1

Effects of CYP3A4*22 and CYP3A5 on clinical outcome in pati..:

Azzahhafi, Jaouad ; Bergmeijer, Thomas O. ; van den Broek, Wout W. A....
Frontiers in Pharmacology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
2

Efficacy and safety of glycoprotein IIb/IIIa inhibitors in ..:

Tavenier, Anne H. ; Claassens, Daniel M. F. ; Hermanides, Renicus S....
Catheterization and Cardiovascular Interventions.  99 (2021)  3 - p. 676-685 , 2021
Link: https://doi.org/10.1002/..
 
?
3

Clopidogrel in noncarriers of CYP2C19 loss-of-function alle..:

Claassens, Daniel M.F. ; Gimbel, Marieke E. ; Bergmeijer, Thomas O....
International Journal of Cardiology.  334 (2021)  - p. 10-17 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in..:

Claassens, Daniel M. F. ; van Dorst, Pim W. M. ; Vos, Gerrit J. A....
American Journal of Cardiovascular Drugs.  22 (2021)  2 - p. 195-206 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Genomewide Association Study of Platelet Reactivity and Car..:

Verma, Shefali Setia ; Bergmeijer, Thomas O. ; Gong, Li...
Clinical Pharmacology & Therapeutics.  108 (2020)  5 - p. 1067-1077 , 2020
Link: https://doi.org/10.1002/..
 
?
6

Tailored P2Y12 inhibitor treatment in patients undergoing n..:

Janssen, Paul W. A. ; Bergmeijer, Thomas O. ; Vos, Gert-Jan A....
European Journal of Clinical Pharmacology.  75 (2019)  9 - p. 1201-1210 , 2019
Link: https://doi.org/10.1007/..
 
?
7

Is there a place for heart-type fatty acid binding protein ..:

Claassens, Daniel M.F. ; Coers, Djura O. ; Bergmeijer, Thomas O...
Emergency Care Journal.  15 (2019)  2 - p. , 2019
Link: https://doi.org/10.4081/..
 
?
8

Genome-wide and candidate gene approaches of clopidogrel ef..:

Bergmeijer, Thomas O. ; Reny, Jean-Luc ; Pakyz, Ruth E....
American Heart Journal.  198 (2018)  - p. 152-159 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Effect of Tailored Antiplatelet Therapy to Reduce Recurrent..:

Godschalk, Thea C. ; Willemsen, Laura M. ; Zwart, Bastiaan...
The American Journal of Cardiology.  119 (2017)  10 - p. 1500-1506 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Ticagrelor or prasugrel versus clopidogrel in elderly patie..:

Qaderdan, Khalid ; Ishak, Maycel ; Heestermans, Antonius A.C.M....
American Heart Journal.  170 (2015)  5 - p. 981-985.e1 , 2015
Link: https://doi.org/10.1016/..
 
?
11

CYP2C19 genotype–guided antiplatelet therapy in ST-segment ..:

Bergmeijer, Thomas O. ; Janssen, Paul W.A. ; Schipper, Jurjan C....
American Heart Journal.  168 (2014)  1 - p. 16-22.e1 , 2014
Link: https://doi.org/10.1016/..
 
?
12

Higher body weight patients on clopidogrel maintenance ther..:

Wagner, Henrik ; Angiolillo, Dominick J. ; ten Berg, Jurrien M....
Journal of Thrombosis and Thrombolysis.  , 2013
Link: https://doi.org/10.1007/..
 
?
13

Value of CYP2C19 *2 and *17 Genotyping in Clinical Practice..:

Bergmeijer, Thomas O. ; ten Berg, Jurriën M.
Revista Española de Cardiología (English Edition).  65 (2012)  3 - p. 205-207 , 2012
Link: https://doi.org/10.1016/..
 
?
14

Effects of CYP3A4*22 and CYP3A5 on clinical outcome in pati..:

Azzahhafi, Jaouad ; Bergmeijer, Thomas O ; van den Broek, Wout W. A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760790/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Efficacy and safety of glycoprotein IIb/IIIa inhibitors in ..:

Tavenier, Anne H ; Claassens, Daniel M.F ; Hermanides, Renicus S...
1522-1946.  , 2022
Link: https://dspace.library.u..
 
1-15